EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Plasma Erythritol Levels and Renal Function Decline in Patients with Type 2 Diabetes: A Retrospective Cohort Study with In Vitro Experiments

Kai Takedani, Masakazu Notsu, Shinichiro Ishihara, Yuta Takagaki, Sabrina Haque, Nesyana Nurmadilla, Salman Ahmad, Ying Zhang, Sho Maejima, Kentaro Matsuzaki, Hiroko Kishi, Keizo Kanasaki

Nutrients · 11.11.2026 · 18 (22) · 3736

DOI: 10.3390/nu18223736 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Nutrients, online erschienen am 11.11.2026. Verfasst von Kai Takedani und 11 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Association for Diabetes Education and Care.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Circulating erythritol has been linked to cardiometabolic disorders, but its association with renal function decline remains unclear. We investigated this association in patients with type 2 diabetes and examined the effects of erythritol on interleukin-6 (IL-6) secretion from tubular cells.

Methods

This retrospective study included 217 patients with baseline estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2. Plasma erythritol and IL-6 concentrations were measured. Renal outcomes were defined as an annual change in eGFR < −2.5 mL/min/1.73 m2 and an eGFR reduction > 30%. Multivariable logistic regression analyses were performed. Human renal proximal tubular epithelial cells (RPTECs) were treated with erythritol for 24 h.

Results

Median follow-up was 50 months. Plasma erythritol concentrations were positively correlated with cardio-ankle vascular index, total plaque score, and plasma IL-6 concentrations, and inversely correlated with baseline eGFR. Among 196 patients with eGFR ≥ 60 mL/min/1.73 m2, higher erythritol concentrations were independently associated with Criterion 1 after adjustment for age, sex, body mass index, eGFR, and urinary albumin-to-creatinine ratio. Erythritol increased IL-6 secretion from RPTECs at 1 and 10 μmol/L.

Conclusions

Plasma erythritol may serve as a functional biomarker and risk marker for subsequent renal function decline in patients with type 2 diabetes and relatively preserved kidney function. Its association with plasma IL-6 concentrations and its effects on RPTEC IL-6 secretion suggest a potential link between erythritol and renal tubular inflammation.

Förderung

  • Japan Association for Diabetes Education and Care

Zitieren

APA

Takedani, K., Notsu, M., Ishihara, S., Takagaki, Y., Haque, S., Nurmadilla, N., Ahmad, S., Zhang, Y., Maejima, S., Matsuzaki, K., Kishi, H., & Kanasaki, K. (2026). Plasma Erythritol Levels and Renal Function Decline in Patients with Type 2 Diabetes: A Retrospective Cohort Study with In Vitro Experiments. Nutrients, 18(22), 3736. https://doi.org/10.3390/nu18223736

Vancouver

Takedani K, Notsu M, Ishihara S, Takagaki Y, Haque S, Nurmadilla N, et al. Plasma Erythritol Levels and Renal Function Decline in Patients with Type 2 Diabetes: A Retrospective Cohort Study with In Vitro Experiments. Nutrients. 2026;18(22):3736. doi:10.3390/nu18223736

BibTeX
@article{Takedani2026,
  author = {Takedani, Kai and Notsu, Masakazu and Ishihara, Shinichiro and Takagaki, Yuta and Haque, Sabrina and Nurmadilla, Nesyana and Ahmad, Salman and Zhang, Ying and Maejima, Sho and Matsuzaki, Kentaro and Kishi, Hiroko and Kanasaki, Keizo},
  title = {Plasma Erythritol Levels and Renal Function Decline in Patients with Type 2 Diabetes: A Retrospective Cohort Study with In Vitro Experiments},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3736},
  doi = {10.3390/nu18223736}
}
Kostenlos starten →